glp 1 agonist vs sglt2 inhibitor Cardiorenal Protection: Potential of Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes | Diabetes Therapy SGLT2 vs GLP-1 for CKD:
Description
Cesta, C
10.1152/ajprenal.00394.2015 18
10.1210/jc.2016-2775 66
Back Heinrich, G, Gros, P, Lund, PK, et al (1984) 'Pre-Proglucagon Messenger Ribonucleic Acid: Nucleotide and Encoded Amino Acid Sequences of the rat pancreatic complementary deoxyribonucleic acid', Endocrinology , 115/6, 2176-81
A.et al (2016b)
Highlights of Prescribing Information FOUNDAYO
